Displaying drugs 426 - 450 of 646 in total
2-Bromoacetyl Group
Experimental
2,6-dibromo-4-[(E)-2-phenylethenyl]phenol
Experimental
Elinogrel
A P2Y12 inhibitor and platelet aggregation inhibitor.
Investigational
Matched Salts name: … Elinogrel potassium …
Tetrabromo-2-Benzotriazole
Experimental
Saprisartan
Saprisartan is an AT1 receptor antagonist. It is based on medications of losartan's prototypical chemical structure. The mode of (functional) AT1 receptor antagonism has been characterized as insurmountable/noncompetitive for saprisartan. It is very likely that slow dissociation kinetics from the AT1 receptor underlie insurmountable antagonism .
Experimental
Matched Salts name: … Saprisartan potassium …
Vaniprevir
Vaniprevir has been used in trials studying the treatment and diagnostic of Hepatitis C, Chronic Hepatitis C, Hepatitis C, Chronic, Chronic Hepatitis C Infection, and Chronic Genotype 1 Hepatitis C Virus Infection.
Investigational
Matched Salts name: … Vaniprevir potassium …
Linsidomine
Experimental
Matched Categories: … Sodium-Potassium-Exchanging ATPase, antagonists & inhibitors …
Tribromometacresol
Experimental
Bibrocathol
Experimental
2-Bromo-6-chloro-purine
Experimental
Volixibat
Volixibat, also known as SHP626 or LUM002, is an investigational drug that will potentially be used for the treatment of Non-Alcoholic Steatohepatitis (NASH). If approved for use, it will be the first available agent for the treatment of NASH.
Volixibat is a selective inhibitor of the apical sodium-dependent bile acid...
Experimental
Investigational
Matched Salts name: … Volixibat potassium …
2,6-dibromo-4-phenoxyphenol
Experimental
4-bromo-3-hydroxy-3-methyl butyl diphosphate
Experimental
o-Bromophenol
Experimental
S-METHYL-4,5,6,7-TETRABROMO-BENZIMIDAZOLE
Experimental
(S)-4-bromo-3-hydroxy-3-methylbutyl diphosphate
Experimental
Isobromindione
Experimental
5-Bromonicotinamide
Experimental
Broxyquinoline
Experimental
Displaying drugs 426 - 450 of 646 in total